USPSTF (United States Preventive Services Task Force). 2002. Screening for Breast Cancer. [Online]. Available: http://www.ahrq.gov/clinic/uspstf/uspsbrca.htm [accessed April 13, 2005].
Ward E, Jemal A, Cokkinides V, Singh GK, Cardinez C, Ghafoor A, Thun M. 2004. Cancer disparities by race/ethnicity and socioeconomic status. CA Cancer J Clin 54(2):78–93.
Washington University School of Medicine. 2004. Comorbidity Coding Course. [Online]. Available: http://cancercomorbidity.wustl.edu [accessed September 13, 2004].
Welch HG, Schwartz LM, Woloshin S. 2000a. Are increasing 5-year survival rates evidence of success against cancer? JAMA 283(22):2975–2978.
Welch HG, Schwartz LM, Woloshin S. 2000b. Do increased 5-year survival rates in prostate cancer indicate better outcomes? JAMA 284(16):2053–2055.
Welch-McCaffrey D, Hoffman B, Leigh SA, Loescher LJ, Meyskens FL Jr. 1989. Surviving adult cancers. Part 2: Psychosocial implications. Ann Intern Med 111(6):517–524.
Wilding G, Remington P. 2005. Period analysis of prostate cancer survival. J Clin Oncol 23(3):407–409.
Yancik R. 1997. Epidemiology of cancer in the elderly. Current status and projections for the future. Rays 22(1 Suppl):3–9.
Yancik R, Ganz PA, Varricchio CG, Conley B. 2001a. Perspectives on comorbidity and cancer in older patients: Approaches to expand the knowledge base. J Clin Oncol 19(4):1147–1151.
Yancik R, Wesley MN, Ries LA, Havlik RJ, Edwards BK, Yates JW. 2001b. Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 years and older. JAMA 285(7):885–892.
Yates JW. 2001. Comorbidity considerations in geriatric oncology research. CA Cancer J Clin 51(6):329–336.